Matthew Flick: New Evidence on SARS-CoV-2 Spike Protein and Clot Formation
Matthew Flick, Professor at University of North Carolina at Chapel Hill, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m excited to report that our latest publication is now available online in Blood Advances – Blood Journals Portfolio.
Here we provide data supporting the idea that the SARS-CoV-2 spike protein conditionally binds fibrin(ogen), but we refute the concept that it influences plasma clot fibrin formation, structure, or lysis.
Outstanding work by lead author Kadri Kangro. Another amazing collaboration with my colleague Alisa Wolberg and her team, namely Samer Issa.”
Title: SARS-CoV-2 spike protein can bind fibrin(ogen), but does not alter plasma fibrin formation, clot structure, or lysis
Authors: Kadri Kangro, Samer M Issa, Alisa S. Wolberg, Matthew J. Flick
Read the Full Article on Blood Advances
Stay updated with Hemostasis Today.
-
Sep 16, 2026, 10:15Massimiliano Camilli: Mechanistic Insights Into Cardiovascular Risk Across Androgen Deprivation Therapies
-
Sep 16, 2026, 09:57Nathan Connell: A Regional Approach to Advancing Contemporary Hemophilia A Care
-
Sep 16, 2026, 09:20Mengistu Abate Belay: Bridging the Gap in Anemia Prevention During Pregnancy
-
Sep 16, 2026, 09:09Younes Kalakhy: When Normal Coagulation Tests Miss von Willebrand Disease
-
Sep 16, 2026, 09:00Test Your Knowledge of Warm Autoimmune Hemolytic Anemia – ASH Education
-
Sep 16, 2026, 08:28Jean Nakhle: Uncovering How Excess Cysteine Drives Cell Death
-
Sep 16, 2026, 08:20Heghine Khachatryan: Arterial and Venous Thrombosis May Require Different Approaches in Neonates
-
Sep 16, 2026, 07:57Tammuella Chrisentery-Singleton: Standing on the Shoulders of Giants in Hemophilia Care
-
Sep 16, 2026, 07:33Jakob Werner Hansen: Nordic VEX AZA Trial Reaches an Important Milestone